Articles
What’s driving the growth of the biopharma sector across South East Asia?
Standfirst: The healthcare industry, particularly the life-science and biopharma sectors, across ASEAN is seeing a shift away from a reliance on overseas expertise and imported products and technology towards a preference for homegrown solutions.
The growth in South East Asia’s...
BioPharma
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy manufacturing for Phase III trials and commercialization. While physical capacity has been blamed, the...
BioPharma
Cell and Gene Therapy CDMO Targets North American Growth with Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
The cell & gene therapy (CGT) CDMO...
BioPharma
Biopharma Spectrum To Be Driven By Automation In Next Decade
One of the reports concerning automation in the biopharmaceutical sector has gone on to show that the market is estimated to grow at a CAGR of 5.7% during the forecast period of 2023–2033. According to the data, the market’s...
BioPharma
New UK Biotech Centres To Boost Cell And Gene Therapies
The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ, stem cell, and tissue transplants in the country, has come up with a new clinical...
BioPharma
Emmes Launches Cell and Gene Therapy Center
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation announced the creation of a dedicated center to enhance Emmes' legacy and depth in cell and gene therapy research.
The new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read